MKI67.md
... ...
@@ -14,12 +14,15 @@ nocite: |
14 14
15 15
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
16 16
17
-|Entity|source |frequency (%)|
18
-|:------:|:---------------------:|:-------------:|
19
-|BL |GAMBL genomes+capture|6.00 |
20
-|BL |Thomas cohort | NA |
21
-|BL |Panea cohort | NA |
22
-|FL |GAMBL genomes |1.15 |
17
+### BL
18
+[[include:tables/BL_MKI67.md]]
19
+
20
+### FL
21
+[[include:tables/FL_MKI67.md]]
22
+
23
+
24
+### DLBCL
25
+[[include:tables/DLBCL_MKI67.md]]
23 26
24 27
## Mutation pattern and selective pressure estimates
25 28
MYO18A.md
... ...
@@ -14,11 +14,15 @@ nocite: |
14 14
15 15
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
16 16
17
-|Entity|source |frequency (%)|
18
-|:------:|:---------------------:|:-------------:|
19
-|BL |GAMBL genomes+capture|4.62 |
20
-|BL |Thomas cohort | NA |
21
-|BL |Panea cohort | NA |
17
+### DLBCL
18
+[[include:tables/DLBCL_MYO18A.md]]
19
+
20
+### FL
21
+[[include:tables/FL_MYO18A.md]]
22
+
23
+### BL
24
+[[include:tables/BL_MYO18A.md]]
25
+
22 26
23 27
## Mutation pattern and selective pressure estimates
24 28
NBEAL1.md
... ...
@@ -14,11 +14,17 @@ nocite: |
14 14
15 15
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
16 16
17
-|Entity|source |frequency (%)|
18
-|:------:|:---------------------:|:-------------:|
19
-|BL |GAMBL genomes+capture|3.46 |
20
-|BL |Thomas cohort | NA |
21
-|BL |Panea cohort | NA |
17
+### BL
18
+[[include:tables/BL_NBEAL1.md]]
19
+
20
+### DLBCL
21
+[[include:tables/DLBCL_NBEAL1.md]]
22
+
23
+### FL
24
+[[include:tables/FL_NBEAL1.md]]
25
+
26
+
27
+
22 28
23 29
## Mutation pattern and selective pressure estimates
24 30
NCOR2.md
... ...
@@ -17,15 +17,8 @@ Mutations in this gene are relatively rare in DLBCL overall but show a pattern o
17 17
18 18
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
19 19
20
-|Entity|source |frequency (%)|
21
-|:------:|:---------------------:|:-------------:|
22
-|BL |GAMBL genomes+capture|6.24 |
23
-|BL |Thomas cohort | NA |
24
-|BL |Panea cohort | NA |
25
-|DLBCL |GAMBL genomes |2.10 |
26
-|DLBCL |Schmitz cohort |5.74 |
27
-|DLBCL |Reddy cohort |3.60 |
28
-|DLBCL |Chapuy cohort |4.27 |
20
+### BL
21
+[[include:tables/BL_NCOR2.md]]
29 22
30 23
## Mutation pattern and selective pressure estimates
31 24
NOA1.md
... ...
@@ -14,11 +14,14 @@ nocite: |
14 14
15 15
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
16 16
17
-|Entity|source |frequency (%)|
18
-|:------:|:---------------------:|:-------------:|
19
-|BL |GAMBL genomes+capture|2.31 |
20
-|BL |Thomas cohort | NA |
21
-|BL |Panea cohort | NA |
17
+### BL
18
+[[include:tables/BL_NOA1.md]]
19
+
20
+### DLBCL
21
+[[include:tables/DLBCL_NOA1.md]]
22
+
23
+### FL
24
+[[include:tables/FL_NOA1.md]]
22 25
23 26
## Mutation pattern and selective pressure estimates
24 27
P2RY2.md
... ...
@@ -14,11 +14,14 @@ nocite: |
14 14
15 15
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
16 16
17
-|Entity|source |frequency (%)|
18
-|:------:|:---------------------:|:-------------:|
19
-|BL |GAMBL genomes+capture|1.15 |
20
-|BL |Thomas cohort | NA |
21
-|BL |Panea cohort | NA |
17
+### BL
18
+[[include:tables/BL_P2RY2.md]]
19
+
20
+### DLBCL
21
+[[include:tables/DLBCL_P2RY2.md]]
22
+
23
+### FL
24
+[[include:tables/FL_P2RY2.md]]
22 25
23 26
## Mutation pattern and selective pressure estimates
24 27
PDCD11.md
... ...
@@ -14,11 +14,14 @@ nocite: |
14 14
15 15
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
16 16
17
-|Entity|source |frequency (%)|
18
-|:------:|:---------------------:|:-------------:|
19
-|BL |GAMBL genomes+capture|3.46 |
20
-|BL |Thomas cohort | NA |
21
-|BL |Panea cohort | NA |
17
+### BL
18
+[[include:tables/BL_PDCD11.md]]
19
+
20
+### DLBCL
21
+[[include:tables/DLBCL_PDCD11.md]]
22
+
23
+### FL
24
+[[include:tables/FL_PDCD11.md]]
22 25
23 26
## Mutation pattern and selective pressure estimates
24 27